Curium launches $1.07 billion term loan at SOFR plus 400-425 bps

By Sara Rosenberg

New York, March 18 – Curium held a lender call at 11 a.m. ET on Monday to launch a $1.065 billion term loan B due July 2029 that is talked at SOFR plus 400 basis points to 425 bps with a 0% floor and a par issue price, according to a market source.

JPMorgan Chase Bank is the lead on the deal.

Proceeds will be used to reprice an existing term loan B down from SOFR plus 450 bps with a 0% floor.

Curium is a nuclear medicine company with headquarters in London and Paris.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.